(Q54672534)

2 June 2018

title

Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. (English)

1 reference

2 June 2018

0 references

8

1 reference

2 June 2018

author name string

Yuko Kuboki

1

1 reference

2 June 2018

Keiko Shiratori

2

1 reference

2 June 2018

Takashi Hatori

3

1 reference

2 June 2018

Izumi Fujita

4

1 reference

2 June 2018

Akira Kimijima

5

1 reference

2 June 2018

Masakazu Yamamoto

6

1 reference

2 June 2018

Makio Kobayashi

7

1 reference

2 June 2018

publication date

21 May 2010

1 reference

2 June 2018

published in

Modern Pathology

1 reference

2 June 2018

volume

23

1 reference

2 June 2018

page(s)

1127-1135

1 reference

2 June 2018

issue

8

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.97

exact match

0 references

cites work

The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Cystic lesions and neoplasms of the pancreas. The features are becoming clearer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Serous cystadenocarcinoma of the pancreas with liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Serous cystadenocarcinoma of the pancreas: management of a rare entity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Macrocystic serous cystadenocarcinoma of the pancreas: the first report of a new pattern of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Cystic lesions of the pancreas. A diagnostic and management dilemma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Common and distinct elements in cellular signaling via EGF and FGF receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

The epidermal growth factor receptor in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Increase in epidermal growth factor receptor and its mRNA levels by parathyroid hormone (1-34) and parathyroid hormone-related protein (1-34) during differentiation of human trophoblast cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.97

7 January 2021

10.1038/MODPATHOL.2010.97

Identifiers

DOI

1 reference

2 June 2018

release_d3cstfcocfcd5nafo6jgmdgv24

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3cstfcocfcd5nafo6jgmdgv24

24 November 2022

mapped directly with Wikidata item

PubMed ID

20495538

1 reference

2 June 2018